Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiuxin Medicine is the specialized Traditional Chinese Medicine (TCM) subsidiary of Jointown Pharmaceutical Group, one of China's largest private pharmaceutical distributors. The company operates an integrated business model covering the entire TCM value chain, including GAP-certified cultivation, standardized processing of decoction pieces, and the manufacturing of finished TCM products. Jiuxin is recognized for its high-quality standards and traceability, marketing products under prominent brands such as "Jiuxin" and "Zhenshantang." By leveraging Jointown's extensive logistics network and digital infrastructure, the company provides standardized TCM solutions to thousands of hospitals and retail pharmacies across China. Jiuxin also focuses on the modernization of TCM through the development of formula granules and innovative health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiuxin Medicine.